# Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study

> **NCT06312722** · NA · RECRUITING · sponsor: **Urotronic Inc.** · enrollment: 92 (estimated)

## Conditions studied

- Benign Prostatic Hyperplasia

## Interventions

- **DEVICE:** Optilume® BPH Catheter System

## Key facts

- **NCT ID:** NCT06312722
- **Lead sponsor:** Urotronic Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-07
- **Primary completion:** 2031-02-07
- **Final completion:** 2031-02-07
- **Target enrollment:** 92 (ESTIMATED)
- **Last updated:** 2026-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06312722

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06312722, "Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06312722. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*